News Related to Vanguard Group Inc.

Related coverage linked through entity extraction aliases.

Moderna Reports Q4 Revenue of $678M, FDA to Review mRNA Flu Vaccine

Mar 21, 2026

Moderna reported Q4 revenues of $678 million, down 29.8% year-over-year but beating analyst expectations. The FDA reversed course and will review the company's mRNA flu vaccine application.

AbbVie Reports Record Sales and Earnings Beat, Advances Clinical Pipeline

Feb 12, 2026

AbbVie reported stronger-than-expected Q4 revenue of $16.62 billion and EPS of $2.71, beating consensus estimates. The company advanced a toxin-based therapy in Phase 2 trials and filed suit challenging Medicare drug-price negotiations for Botox.